Literature DB >> 5947321

Free sugars in alloxan diabetic rat nerve.

M A Stewart, W R Sherman, S Anthony.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1966        PMID： 5947321     DOI： 10.1016/0006-291x(66)90300-7

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN： 0006-291X            Impact factor:   3.575


× No keyword cloud information.
  11 in total

1.  Morphological abnormalities of the terminal neuromuscular apparatus in recent juvenile diabetes.

Authors:  E Reske-Nielsen; G Gregersen; A Harmsen; K Lundbaek
Journal:  Diabetologia       Date:  1970-04       Impact factor: 10.122

2.  Pathological changes in the central and peripheral nervous system of young long-term diabetics. II. The spinal cord and peripheral nerves.

Authors:  E Reske-Nielsen; K Lundbaek
Journal:  Diabetologia       Date:  1968-01       Impact factor: 10.122

3.  Variations in motor conduction velocity produced by acute changes of the metabolic state in diabetic patients.

Authors:  G Gregersen
Journal:  Diabetologia       Date:  1968-11       Impact factor: 10.122

4.  The polyol pathway. A historical review.

Authors:  R S Clements
Journal:  Drugs       Date:  1986       Impact factor: 9.546

5.  Dyslipidemia impairs mitochondrial trafficking and function in sensory neurons.

Authors:  Amy E Rumora; Stephen I Lentz; Lucy M Hinder; Samuel W Jackson; Andrew Valesano; Gideon E Levinson; Eva L Feldman
Journal:  FASEB J       Date:  2017-09-13       Impact factor: 5.191

Review 6.  Search for a biochemical basis of diabetic microangiopathy.

Authors:  R G Spiro
Journal:  Diabetologia       Date:  1976-03       Impact factor: 10.122

7.  Axonopathy and microangiopathy in chronic alloxan diabetes.

Authors:  H C Powell; R R Myers
Journal:  Acta Neuropathol       Date:  1984       Impact factor: 17.088

Review 8.  Diabetic autonomic neuropathy.

Authors:  B F Clarke; D J Ewing; I W Campbell
Journal:  Diabetologia       Date:  1979-10       Impact factor: 10.122

9.  Hemorheologic and hemostatic changes in long-standing insulin-dependent (type I) diabetic patients with peripheral and autonomic cardiovascular neuropathy.

Authors:  S B Solerte; M Fioravanti; N Schifino; A L Patti; G Gamba; E Ferrari
Journal:  Acta Diabetol Lat       Date:  1988 Jul-Sep

10.  Effect of a new aldose reductase inhibitor, (E)-3-carboxymethyl-5-[(2E)-methyl-3-phenylpropenylidene]rhodanine (ONO-2235) on peripheral nerve disorders in streptozotocin-diabetic rats.

Authors:  R Kikkawa; I Hatanaka; H Yasuda; N Kobayashi; Y Shigeta; H Terashima; T Morimura; M Tsuboshima
Journal:  Diabetologia       Date:  1983-04       Impact factor: 10.122
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.